scispace - formally typeset
P

Patrik Brundin

Researcher at Van Andel Institute

Publications -  253
Citations -  28163

Patrik Brundin is an academic researcher from Van Andel Institute. The author has contributed to research in topics: Parkinson's disease & Transplantation. The author has an hindex of 77, co-authored 232 publications receiving 24428 citations. Previous affiliations of Patrik Brundin include Mayo Clinic & Lund University.

Papers
More filters
Journal ArticleDOI

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith, +95 more
- 04 Jul 2017 - 
TL;DR: The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade.
Journal ArticleDOI

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

TL;DR: Two subjects with Parkinson's disease who had long-term survival of transplanted fetal mesencephalic dopaminergic neurons (11–16 years) developed α-synuclein–positive Lewy bodies in grafted neurons, providing the first evidence, to the authors' knowledge, that the disease can propagate from host to graft cells.
Journal ArticleDOI

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

TL;DR: The grafts, which were implanted unilaterally into the putamen by stereotactic surgery, restored dopamine synthesis and storage in the grafted area, as assessed by positron emission tomography with 6-L-[18F]fluorodopa.
Journal ArticleDOI

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

TL;DR: Recent findings indicate that the ubiquitin-proteasome system is involved in the pathogenesis of Parkinson's, Alzheimer's, Huntington's, and Prion diseases as well as amyotrophic lateral sclerosis, which raises hopes for a better understanding of the pathogenetic mechanisms involved in these diseases and for the development of novel, mechanism-based therapeutic modalities.
Journal ArticleDOI

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

TL;DR: In vivo transfer of α-syn between host cells and grafted dopaminergic neurons in mice overexpressing human α- syn and results suggest that α- Syn propagation is a key element in the progression of Parkinson disease pathology.